Receive our newsletter – data, insights and analysis delivered to you
  1. Uncategorised
February 3, 2021

Coronavirus company news summary – Novacyt launches PCR genotyping assay portfolio to detect Covid-19 variants – Omega launches Covid-19 PCR testing for all variants

By Chloe Kent

Novacyt, a biotechnology group focused on clinical diagnostics, announced the launch of a portfolio of assays under the name SNPsig to help in the diagnosis of the new SARS-CoV-2 variants. The new SNPsig portfolio complements and supports the need for PCR genotyping of variants, which emerged across the world in the latter part of 2020.

eMed, a digital health company, has announced a collaboration with the State of Colorado to administer approximately two million virtually guided BinaxNOW at-home Covid-19 rapid tests per month. The tests reveal results within minutes and are expected to aid in the safe re-opening of schools.

Omega Laboratories has launched a new suite of Covid-19 laboratory testing services, and now offers PCR testing for the disease. Omega’s Research & Development team is also hard at work validating COVID-19 oral fluid testing and laboratory-based antibody testing in the coming months.

Related Companies

Content from our partners
Precision wire: The future of bespoke medical treatment
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
“This technique means everything to us”: How CGM devices empower users 
Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU